Copyright © 2000 by the European Society of Cardiology.
Population Sciences Lecture
Clinical and research challenges in risk factors for cardiovascular diseases
University of Miami School of Medicine, Miami, Florida, U.S.A.
revised April 24, 2000; accepted April 24, 2000
f1 Correspondence: Charles W. Hennekens, MD, Visiting Professor of Medicine, 1415 West Camino Real, Boca Raton, FL 33486, U.S.A.
References
- Conner LA. The American Heart Journal. Am Heart J. 1925;1:115116[CrossRef]
- Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation. 1998;97:10951102
[Free Full Text] - Hoyert, DL, Kochanek, KD, Murphy, SL, Deaths: final data for 1997. (National Vital Statistics Reports vol 47, no 19), Hyattsville, Maryland, National Center for Health Statistics, 1999
- Eur Heart J. 1998;19:14341503
[Free Full Text] - Murray CJL, Lopez AD. The Global Burden of Disease. Cambridge: Harvard School of Public Health; 1996.
- Robertson TL, Kato H, Gordon T. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol. 1977;39:244249[CrossRef][Web of Science][Medline]
- Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med. 2000;160:422434
[Abstract/Free Full Text] - Ma J, Hennekens CH, Ridker PM, Stampfer MJ. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol. 1999;33:13471352
[Abstract/Free Full Text] - Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973979
[Abstract/Free Full Text] - Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836843
[Abstract/Free Full Text] - Manson JE, Tosteson H, Ridker PM. The primary prevention of myocardial infarction. N Engl J Med. 1992;326:14061416[Web of Science][Medline]
- Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. J Am Med Assoc. 1997;278:313321
[Abstract/Free Full Text] - LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. J Am Med Assoc. 1999;282:23402346
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
C. H Hennekens and R. B D'Agostino Global risk assessment for cardiovascular disease and astute clinical judgement Eur. Heart J., November 1, 2003; 24(21): 1899 - 1900. [Full Text] [PDF] |
||||
![]() |
R. S. Eidelman, G. A. Lamas, and C. H. Hennekens The New National Cholesterol Education Program Guidelines: Clinical Challenges for More Widespread Therapy of Lipids to Treat and Prevent Coronary Heart Disease Arch Intern Med, October 14, 2002; 162(18): 2033 - 2036. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

